Exploring the Future of Clinical Trials pt. 1 feat. Bristol Myers Squibb's Marisa Co and Gaelan Ritter Artwork

The ConcertAI Podcast

Dive into the innovative world of oncology research with The ConcertAI Podcast! ConcertAI uses artificial intelligence to revolutionize the clinical development and delivery of cancer treatments, accelerating the delivery of precision oncology to patients in need. With real-world data, clinical trial matching, patient support, and more, ConcertAI is transforming the oncology landscape. These are rapidly changing fields which require very high expertise. Tune in twice a month as we bring subject matter experts together to take a deeper dive on topics of interest and relevance.To learn more about ConcertAI please visit us at www.ConcertAI.com

All Episodes

The ConcertAI Podcast

Exploring the Future of Clinical Trials pt. 1 feat. Bristol Myers Squibb's Marisa Co and Gaelan Ritter

April 18, 2023 • ConcertAI • Season 1 • Episode 7

A 2-Part Special with Bristol Myers Squibb on the Digitally Accelerated Clinical Trial (DACT) Model.

In part 1, we will be joined by Marissa Co, Vice President of R&D Business Insights & Analytics, and Gaelan Ritter, Head of Analytics Innovation and Digital Health, who shed light on the exciting ways clinical trials are evolving and improving patient outcomes. The team at Bristol Myers Squibb will be discussing their groundbreaking work using the Digitally Accelerated Clinical Trial (DACT) model in the biopharma industry which leverages automation and integrates with various clinical data sources to collect more data and improve trial efficiency. This not only allows for more rapid completion of trials, but also facilitates the identification of eligible patients.

Join us as we explore these exciting developments and learn how they are changing the biopharma landscape.

Website
www.ConcertAI.com

LinkedIn
www.linkedin.com/company/concertai/

Twitter
www.twitter.com/concertai

People on this episode

Jeff Elton, PhD

Host